top of page
Our first-in-class drug discovery pipeline for true anti-metastatic drugs is powered by TumorGen's proprietary discovery engine. Ultimately, the goal of this pipeline is to develop new therapies that can effectively prevent metastasis, the major cause of cancer-related deaths.
The effect of a tool compound targeting
cancer cell cluster adhesion
Disassociating metastatic cancer cell clusters, thus stopping metastasis, is a promising therapeutic strategy strongly supported by established research.
We are focused on three major pathways that show promise in targeting metastatic cell clusters.
bottom of page